Microbial Metabolite 4EPS Inhibits AT1R to Reduce Blood Pressure and Aortic Aneurysm Outcome
Published in Hypertension, 2026
Plasma accumulation of the gut microbial metabolite 4-ethylphenylsulfate (4EPS), derived from dietary amino acid, tyrosine, has been associated with cardiovascular, renal, metabolic, and neurological disorders. AngII (angiotensin II) infusion increases circulating 4EPS in mice, suggesting a potential mechanistic role. We hypothesized that 4EPS modulates AngII-regulated pathophysiology and disease progression by directly inhibiting AT1R (angiotensin II type 1 receptor).
Recommended citation: Harford TJ, Singh KD, Pardhi TR, Desnoyer R, Ravi T, Jara ZP, Zalavadia A, Stenson K, Naga Prasad SV, Karnik SS. Microbial Metabolite 4EPS Inhibits AT1R to Reduce Blood Pressure and Aortic Aneurysm Outcome. Hypertension. 2026 Jan 22. doi: 10.1161/HYPERTENSIONAHA.125.25364. PMID: 41568432. https://www.ahajournals.org/doi/epub/10.1161/HYPERTENSIONAHA.125.25364
